title: [Frontline of vascular regenerative therapy for refractory peripheral arterial diseases].
authors.forename: Masaaki
authors.initials: M
authors.lastname: Miyamoto
authors.forename: Hajime
authors.initials: H
authors.lastname: Takagi
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Kubota
authors.forename: Akihito
authors.initials: A
authors.lastname: Tetsuka
authors.forename: Shuhei
authors.initials: S
authors.lastname: Tara
authors.forename: Wataru
authors.initials: W
authors.lastname: Shimizu
authors.forename: Yoshimitsu
authors.initials: Y
authors.lastname: Fukushima
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Kumida
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Tabata
mesh_terms: D001162:Arteriosclerosis Obliterans / Q000628:therapy; D064592:Autografts; D016026:Bone Marrow Transplantation; D016503:Drug Delivery Systems; D005346:Fibroblast Growth Factors / Q000008:administration & dosage; D005780:Gelatin; D019220:High-Energy Shock Waves; D006801:Humans; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D007273:Injections, Intramuscular; D058729:Peripheral Arterial Disease / Q000628:therapy*; D044968:Regenerative Medicine / Q000379:methods* / Q000639:trends*; D045743:Scleroderma, Diffuse / Q000628:therapy; D013234:Stem Cells; D013919:Thromboangiitis Obliterans / Q000628:therapy
chemical_list: D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D005346:Fibroblast Growth Factors; D005780:Gelatin